Dieses Portal verwendet Cookies zur Optimierung der Browserfunktion. Informieren Sie sich, wie wir Cookies verwenden und wie Sie Ihre Einstellungen ändern können.
das Vereinigte Königreich-Aldgate: Patienten-Fernüberwachungssystem
Bekanntmachung über Änderungen oder zusätzliche Angaben
(Supplement zum Amtsblatt der Europäischen Union, 2019/S 083-197406)
Abschnitt I: Öffentlicher Auftraggeber/Auftraggeber
Adresse des Beschafferprofils: http://www.bartshealth.nhs.uk
Abschnitt II: Gegenstand
Bart's Health NHS Trust Cancer Services — Chemotherapy Prescribing and Clinical Audit
Barts Health NHS Trust requires a single, specialist chemotherapy electronic prescribing system for cancer services for use across the Trust.
This system must deliver full compliance with prevailing UK legal requirements, standards of practice, data-set submissions and NHS information governance frameworks. In doing so, it will provide a complete and chronological Electronic Patient Record (EPR) of all contact with the cancer services team. This will include prescribing, reviewing, referring, compounding, dispensing, reporting and administering systemic anti-cancer chemotherapy for solid tumour, haemato-oncology and paediatric services.
The solution needs to have the capability of interfacing with numerous IT systems to provide both clinical and administrative functions, with the ability to support services that are located across multiple sites, both in acute (hospital) and community/outpatient settings.
Abschnitt VI: Weitere Angaben
Abschnitt VII: Änderungen
The service provider will be expected to implement an oncology e-prescribing system within the St Barts Hospital production environment with full compatibility and integration of services within 6-12 months of contract sign off for a period of 3 years + one (1 + 1) year extension.
The supplier will be contracted for the supply and maintenance of a Chemotherapy Electronic Prescribing and Medicines Administration Information Technology (IT) System which must include:
— solid tumours, and
— paediatric oncology.
The new solution must have the capability of integrating with other software used within the Trust and external to the Trust. For example, the Trust’s current Electronic Patient Records (EPR), Cerner Millennium, across all Trust’s sites plus pathology results from Clinisys WinPath. The solution must also support data sharing to regional data sharing tools, such as Cerner’s Health Information Exchange.
The oncology e-prescribing solution needs to have been in a production environment in at least three UK NHS or private health facilities for at least 12 months.